基于 1 个已确定 T+90 收益的买入信号。收益基准:公布次日的收盘价。
Explore the full record of transactions filed by Manning Meredith. Director active across 1 company, notably Soleno Therapeutics INC. In total, 7 reports have been recorded. Breakdown: 0 buy · 4 sells. Total volume traded: €240k. History available since 17 July 2024. The latest transaction was filed on 27 March 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Manning Meredith is a declarant linked to Soleno Therapeutics INC, where the listed role is Chief Commercial Officer. The record shows 6 filings in total, and across the sampled recent filings from 2024-07-19 to 2026-03-31, the total sell amount is EUR 239530, with the modal transaction nature listed as sell.